Unilateral hippocampal wasting after combined-modality therapy for glioblastoma

Acta Oncol. 2018 May;57(5):688-691. doi: 10.1080/0284186X.2017.1398412. Epub 2017 Nov 10.

Authors

Tyler M Seibert¹, Yoseph Dalia¹, Roshan Karunamuni¹, David Piccioni², Carrie R McDonald^{1

3}, Nikdokht Farid⁴, Jona A Hattangadi-Gluth¹

Affiliations

¹ a Department of Radiation Medicine and Applied Sciences , University of California , San Diego, La Jolla , CA , USA.
² b Department of Neurosciences , University of California , San Diego, La Jolla , CA , USA.
³ c Department of Psychiatry , University of California , San Diego, La Jolla , CA , USA.
⁴ d Department of Radiology , University of California , San Diego, La Jolla , CA , USA.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Atrophy / diagnosis
Atrophy / etiology
Brain Neoplasms / pathology
Brain Neoplasms / therapy*
Chemoradiotherapy / adverse effects*
Chemoradiotherapy / methods
Combined Modality Therapy / adverse effects
Glioblastoma / pathology
Glioblastoma / therapy*
Hippocampus / diagnostic imaging
Hippocampus / pathology*
Humans
Magnetic Resonance Imaging
Male
Neurosurgical Procedures / adverse effects*
Organ Size
Young Adult

Grants and funding